Patrick McCall
Director of Finance/CFO at IN8BIO, INC.
Net worth: 31 571 $ as of 30/03/2024
Profile
Patrick McCall is currently the Chief Financial Officer & Secretary at IN8bio, Inc. Prior to his current position, he worked as the Controller at Catalyst Biosciences, Inc. and as the Vice President-Finance at Turnstone Biologics Corp.
from 2018 to 2021.
Mr. McCall completed his undergraduate degree at Drexel University and holds an MBA from Cornell University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IN8BIO, INC.
0.06% | 06/02/2024 | 26,755 ( 0.06% ) | 31 571 $ | 30/03/2024 |
Patrick McCall active positions
| Companies | Position | Start |
|---|---|---|
| IN8BIO, INC. | Director of Finance/CFO | 07/02/2021 |
Former positions of Patrick McCall
| Companies | Position | End |
|---|---|---|
| TURNSTONE BIOLOGICS CORP. | Director of Finance/CFO | 31/01/2021 |
| CATALYST BIOSCIENCES | Comptroller/Controller/Auditor | - |
Training of Patrick McCall
| Drexel University | Undergraduate Degree |
| Cornell University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| IN8BIO, INC. | Health Technology |
| TURNSTONE BIOLOGICS CORP. | Health Technology |
| Private companies | 1 |
|---|---|
Catalyst Biosciences, Inc.
 Catalyst Biosciences, Inc. BiotechnologyHealth Technology Catalyst Biosciences, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Patrick McCall
